Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ANKRD55 |
| Upstream (Parents) |
|---|
| (<<) GAMT → ANKRD55 |
| (<<) MT1P2///MT1M///MT1H///MT1E → ANKRD55 |
| (<<) ATF5 → ANKRD55 |
| Downstream (Children) |
|---|
| ANKRD55 → SLC26A6///CELSR3 (>>) |
| ANKRD55 → TMEM156 (>>) |
| ANKRD55 → INTS1 (>>) |
| ANKRD55 → CHERP (>>) |
| ANKRD55 → C20orf195 (>>) |
| ANKRD55 → PGA4///PGA3///PGA5 (>>) |
| ANKRD55 → RAP2A (>>) |
| ANKRD55 → NEU2 (>>) |
| ANKRD55 → CREB5 (>>) |
| ANKRD55 → SLC2A10 (>>) |
| ANKRD55 → LRRC23 (>>) |
| ANKRD55 → POLR2J3///POLR2J2///POLR2J4///POLR2J (>>) |
